HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Putzer Selected Research

Daniel Putzer Research Topics

Disease

22Neoplasms (Cancer)
01/2022 - 08/2009
9Neoplasm Metastasis (Metastasis)
09/2021 - 08/2009
5Hepatocellular Carcinoma (Hepatoma)
05/2020 - 01/2018
4Glioma (Gliomas)
01/2014 - 11/2011
3Breast Neoplasms (Breast Cancer)
09/2021 - 09/2019
3Thyroid Neoplasms (Thyroid Cancer)
12/2015 - 06/2012
2Cholangiocarcinoma
01/2022 - 05/2020
2Carcinoma (Carcinomatosis)
10/2013 - 08/2012
2Hyperparathyroidism
01/2010 - 09/2008
2Neuroendocrine Tumors (Neuroendocrine Tumor)
09/2009 - 08/2009
1Fibrosis (Cirrhosis)
04/2022
1Inflammation (Inflammations)
04/2022
1Liver Diseases (Liver Disease)
04/2022
1Liver Cell Adenoma (Hepatocellular Adenoma)
01/2022
1Pneumothorax
05/2021
1Hemorrhage
05/2021
1Chronic Disease (Chronic Diseases)
05/2020
1Hypotension (Low Blood Pressure)
01/2018
1Tick-Borne Encephalitis (Encephalitis, Tick Borne)
10/2016
1Colorectal Neoplasms (Colorectal Cancer)
03/2014
1Squamous Cell Carcinoma of Head and Neck
09/2013
1Brain Neoplasms (Brain Tumor)
03/2013
1Prostatic Neoplasms (Prostate Cancer)
08/2012
1Leukemia
04/2012
1Pain (Aches)
07/2011
1Hyperalgesia
07/2011
1Secondary Hyperparathyroidism
11/2009
1Primary Hyperparathyroidism
09/2008

Drug/Important Bio-Agent (IBA)

2Glucose (Dextrose)FDA LinkGeneric
10/2016 - 12/2015
21,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
12/2015 - 09/2009
2Octreotide (Sandostatin)FDA LinkGeneric
12/2015 - 09/2013
2Somatostatin Receptors (Somatostatin Receptor)IBA
12/2015 - 08/2009
2Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
04/2014 - 08/2009
2Radioisotopes (Radionuclides)IBA
10/2013 - 09/2009
2Tyrosine (L-Tyrosine)FDA Link
07/2013 - 03/2013
1NADPH Oxidase 4IBA
04/2022
1Interleukin-11 (Interleukin 11)IBA
04/2022
1Ethanol (Ethyl Alcohol)IBA
04/2022
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
04/2022
1JNK Mitogen-Activated Protein KinasesIBA
04/2022
1Capsules (Microcapsules)IBA
01/2022
1Hormones (Hormone)IBA
08/2021
1Anesthetics (Anesthetic Agents)IBA
05/2021
1SirtuinsIBA
09/2019
1iopromide (Ultravist)FDA Link
01/2018
1iodixanol (Visipaque)FDA Link
01/2018
1LigandsIBA
12/2015
1lanreotide (Somatuline)FDA Link
12/2015
1Immunomodulating AgentsIBA
03/2014
1Lenalidomide (CC 5013)FDA Link
03/2014
1NucleosidesIBA
01/2014
1Amino AcidsFDA Link
01/2014
1alovudineIBA
01/2014
1Cisplatin (Platino)FDA LinkGeneric
10/2013
1GemcitabineFDA Link
10/2013
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
10/2013
1Peptide Receptors (Peptide Receptor)IBA
10/2013
1Edotreotide (SMT 487)IBA
09/2013
1Androgen Antagonists (Antiandrogens)IBA
08/2012
1Choline (Choline Chloride)IBA
08/2012
1Bortezomib (Velcade)FDA Link
06/2012
1Proteasome InhibitorsIBA
06/2012
1Glycoproteins (Glycoprotein)IBA
11/2011
1Peptides (Polypeptides)IBA
11/2011
1Biological ProductsIBA
11/2011
1RadiopharmaceuticalsIBA
11/2011
1Parathyroid Hormone (Parathormone)IBA
09/2008

Therapy/Procedure

23Radiofrequency Ablation
01/2022 - 01/2019
7Therapeutics
09/2019 - 09/2009
1Palliative Care (Palliative Therapy)
01/2022
1Chest Tubes (Chest Tube)
05/2021
1Ablation Techniques
10/2019
1Radiotherapy
09/2019
1Intravenous Administration
01/2018
1Liver Transplantation
01/2018
1Drug Therapy (Chemotherapy)
10/2013
1Prostatectomy (Retropubic Prostatectomy)
08/2012
1Radioimmunotherapy
04/2012
1Stem Cell Transplantation
04/2012
1Electrodes (Electrode)
07/2011
1Minimally Invasive Surgical Procedures
01/2010
1Kidney Transplantation
11/2009
1Thyroidectomy
09/2008